Back
Precigen 10K Form
Sell
47
PGEN
Precigen
Last Price:
0.95
Seasonality Move:
3.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PGEN News And Ratings
See the #1 stock for the next 7 days that we like better than PGEN
PGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $6.23M |
|---|---|
| Cash Flow: | $-23.62M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.19 |
| Price / Book: | 4.78 |
Profitability
| EPS (TTM): | -0.55000 |
|---|---|
| Net Income (TTM): | $-139.56M |
| Gross Margin: | $106K |
| Return on Equity: | -151.13% |
| Return on Assets: | -110.2% |
Precigen Earnings Forecast
Key Precigen Financial Ratios
- The Gross Profit Margin over the past 12 years for PGEN is 1.70%.
- The Selling, General & Administrative Expenses for PGEN have been equal to 649.24% of Gross Profit Margin.
- The Research & Development expenses have been 780.95% of Revenue.
- The Interest Expense is -0.49% of Operating Income.
- The Net Earning history of PGEN is -1,540.63% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 7 years.
Precigen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PGEN |
| CUSIP: | 74017N |
| Website: | precigen.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.63 |
| Quick Ratio: | 1.38 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |